Skip to main content
Livermore
Livermore
ZHEN

Dempze Nancy E

SEC CIK
0001592614
Latest filing
Aug 12, 2026

The latest 13F from Dempze Nancy E covers Q2 2026 (filed Aug 12, 2026): 91 long positions worth $209.0M. The top 10 holdings make up 42.3% of the portfolio, and the largest is Alphabet Inc. (GOOGL) at 5.4%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
5
Est. +$1.09M
Added
23
Est. +$5.60M
Reduced
34
Est. −$8.18M
Sold out
6
Est. −$1.47M

Top 5 holdings

Share of this quarter's portfolio value

  1. GOOGLAlphabet Inc.
    5.4%$11.3MHistory
  2. NVDANVIDIA Corp
    5.3%$11.1MHistory
  3. AMDAdvanced Micro Devices Inc
    5.1%$10.6MHistory
  4. AAPLApple Inc.
    4.5%$9.46MHistory
  5. AMATApplied Materials Inc
    4.5%$9.44MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. AXPAmerican Express Co
    +$758.7KAddedHistory
  2. WCNWaste Connections, Inc.
    +$745.3KAddedHistory
  3. NEENextera Energy Inc
    +$738.1KAddedHistory
  4. AVGOBroadcom Inc.
    +$626.7KAddedHistory
  5. LLYEli Lilly & Co
    +$430.6KAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. AMATApplied Materials Inc
    +2.15 pp2.4% → 4.5%History
  2. LLYEli Lilly & Co
    +0.59 pp2.8% → 3.4%History
  3. AVGOBroadcom Inc.
    +0.33 pp0.5% → 0.8%History
  4. WCNWaste Connections, Inc.
    +0.33 pp0.3% → 0.6%History
  5. AXPAmerican Express Co
    +0.32 pp1.6% → 1.9%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. UNHUnitedHealth Group Inc
    −$1.72MReducedHistory
  2. AMDAdvanced Micro Devices Inc
    −$971.9KReducedHistory
  3. ADIAnalog Devices Inc
    −$587.4KReducedHistory
  4. FISVFiserv Inc
    −$573.1KReducedHistory
  5. CARRCarrier Global Corp
    −$521.7KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ABTAbbott Laboratories
    −0.66 pp2.5% → 1.8%History
  2. RTXRTX Corp
    −0.55 pp3.4% → 2.9%History
  3. UNHUnitedHealth Group Inc
    −0.44 pp1.1% → 0.7%History
  4. DHRDanaher Corp
    −0.42 pp2.2% → 1.8%History
  5. FISVFiserv Inc
    −0.39 pp0.5% → 0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$209.0M
+$26.9M (+14.8%) vs. prior quarter
Positions
91
−1 vs. prior quarter
Top 10 concentration
42.3%
Top 10 as share of value
Turnover
3.4%
Q2 2026, one quarter
Average holding period
17.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $209.0M (Q2 2026)

Q1 2021: $113.1MQ2 2021: $118.6MQ3 2021: $127.5MQ4 2021: $148.2MQ1 2022: $136.9MQ2 2022: $99.5MQ3 2022: $93.9MQ4 2022: $102.5MQ1 2023: $109.9MQ2 2023: $116.7MQ3 2023: $111.3MQ4 2023: $119.6MQ1 2024: $131.3MQ2 2024: $145.7MQ3 2024: $179.2MQ4 2024: $173.2MQ1 2025: $166.6MQ2 2025: $173.4MQ3 2025: $182.1MQ4 2025: $192.0MQ1 2026: $182.1MQ2 2026: $209.0M
Q1 2021Q2 2026
13F filings of Dempze Nancy E by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 12, 202691$209.0MGOOGLNVDAAMDvs. Q1 2026SEC
Q1 2026May 14, 202692$182.1MNVDAGOOGLAAPLvs. Q4 2025SEC
Q4 2025Feb 17, 202698$192.0MNVDAGOOGLMSFTvs. Q3 2025SEC
Q3 2025Nov 10, 202586$182.1MNVDAGOOGLMSFTvs. Q2 2025SEC
Q2 2025Jul 23, 202592$173.4MNVDAMSFTAAPLvs. Q1 2025SEC
Q1 2025May 6, 202593$166.6MNVDAAAPLMAvs. Q4 2024SEC
Q4 2024Feb 13, 202595$173.2MNVDAAAPLGOOGLvs. Q3 2024SEC
Q3 2024Nov 12, 2024101$179.2MNVDAAAPLMSFTvs. Q2 2024SEC
Q2 2024Aug 12, 202481$145.7MNVDAMSFTAAPLvs. Q1 2024SEC
Q1 2024May 14, 202462$131.3MNVDAMSFTMAvs. Q4 2023SEC
Q4 2023Feb 14, 202458$119.6MAAPLMSFTGOOGLvs. Q3 2023SEC
Q3 2023Nov 14, 202364$111.3MAAPLMSFTGOOGLvs. Q2 2023SEC
Q2 2023Aug 14, 202363$116.7MAAPLMSFTADIvs. Q1 2023SEC
Q1 2023May 11, 202365$109.9MAAPLADIMSFTvs. Q4 2022SEC
Q4 2022Feb 9, 202363$102.5MADPAAPLDHRvs. Q3 2022SEC
Q3 2022Nov 8, 202264$93.9MAAPLADPDHRvs. Q2 2022SEC
Q2 2022Jul 19, 202267$99.5MAAPLADPDHRvs. Q1 2022SEC
Q1 2022May 17, 202278$136.9MAAPLGOOGLDHRvs. Q4 2021SEC
Q4 2021Feb 8, 202279$148.2MAAPLDHRGOOGLvs. Q3 2021SEC
Q3 2021Nov 10, 202176$127.5MAAPLDHRGOOGLvs. Q2 2021SEC
Q2 2021Aug 9, 202166$118.6MAAPLDHRGOOGLvs. Q1 2021SEC
Q1 2021May 17, 202168$113.1MAAPLABTDHR–SEC